Evercore ISI Reaffirms Their Buy Rating on KKR & Co (KKR)
Evercore ISI analyst Glenn Schorr maintained a Buy rating on KKR & Co (KKR – Research Report) yesterday and set a price target of $165.00.
Cotiviti nears $3bn acquisition of Edifecs, rejects UnitedHealth's higher bid, FT reports
Cotiviti, a healthcare data company backed by KKR, is reportedly on the brink of finalizing a deal to acquire its smaller ...
KKR-backed Cotiviti nears deal for rival healthcare data group Edifecs
KKR-backed healthcare data company Cotiviti is close to securing a deal to buy smaller rival Edifecs for just over $3bn, after it opted against accepting a higher bid from UnitedHealth Group out of ...
KKR-backed Cotiviti close to deal to buy Edifecs for $3B - FT
Cotiviti nears $3 billion deal to acquire Edifecs, rejecting higher bid from UnitedHealth. Antitrust concerns cited.